Chinese Journal of Pharmacovigilance ›› 2023, Vol. 20 ›› Issue (10): 1121-1128.
DOI: 10.19803/j.1672-8629.20220655
Previous Articles Next Articles
WANG Rumeng1, GUO Ziqi2, YANG Hongxin1,*, YANG Yong2,#
Received:
2022-11-09
Online:
2023-10-15
Published:
2023-10-16
CLC Number:
WANG Rumeng, GUO Ziqi, YANG Hongxin, YANG Yong. Mechanisms of Piper longum for treating gastric cancer based on network pharmacology and molecular docking[J]. Chinese Journal of Pharmacovigilance, 2023, 20(10): 1121-1128.
[1] WEI L, SUN J, ZHANG N, et al.Noncoding RNAs in gastric cancer: implications for drug resistance[J]. Mol Cancer, 2020, 19(1): 62-79. [2] GULLO I, GRILLO F, MASTRACCI L, et al.Precancerous lesions of the stomach, gastric cancer and hereditary gastric cancer syndromes[J]. Pathologica, 2020, 112(3): 166-185. [3] SHAN C, ZHANG Y, HAO X, et al.Biogenesis, functions and clinical significance of circRNAs in gastric cancer[J]. Mol Cancer, 2019,18(1): 136-151. [4] GULLO I, GRILLO F, MASTRACCI L, et al.Precancerous lesions of the stomach, gastric cancer and hereditary gastric cancer syndromes[J]. Pathologica, 2020,112(3): 166-185. [5] SMYTH EC, NILSSON M, GRABSCH HI, et al.Gastric cancer[J]. Lancet, 2020, 396(10251): 635-648. [6] CHEN H, LIANG C, WANG X, et al.The prognostic value of circRNAs for gastric cancer: a systematic review and meta-analysis[J]. Cancer Med, 2020, 9(23): 9096-9106. [7] ZHANG Y, ZHU C, LU X.Advances in serum biomarkers for early diagnosis of gastric cancer[J]. Journal of ZheJiang University Medical Sciences(浙江大学学报医学版), 2019, 48(3): 326-333. [8] WU JY, LEE YC, GRAHAM DY, et al.The eradication of Helicobacter pylori to prevent gastric cancer: a critical appraisal[J]. Expert Rev Gastroenterol Hepato, 2019, 13(1): 17-24. [9] GULLO I, GRILLO F, MASTRACCI L, et al.Precancerous lesions of the stomach, gastric cancer and hereditary gastric cancer syndromes[J]. Pathologica, 2020, 112(3): 166-185. [10] LI TT, LIU H, YU J, et al.Prognostic and predictive blood biomarkers in gastric cancer and the potential application of circulating tumor cells[J]. World J Gastroenterol, 2018, 24(21): 2236-2246. [11] MACHLOWSKA J, BAJ J, SITARZ M, et al.Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies[J]. Int J Mol Sci, 2020, 21(11): 4012-4032. [12] KHATAMI Z, HERDLINGER S, SARKHAIL P, et al.Isolation and characterization of acetylcholinesterase inhibitors from Piper longum and binding mode predictions[J]. Planta Med, 2020, 86(15): 1118-1124. [13] ZHANG L, XIAO Y, YANG R, et al.Systems pharmacology to reveal multi-scale mechanisms of traditional Chinese medicine for gastric cancer[J]. Sci Rep, 2021, 11(1): 22149-22161. [14] LIM HJ, BAK SG, PARK EJ, et al.Retrofractamide C derived from Piper longum alleviates Xylene-Induced mouse ear edema and inhibits phosphorylation of ERK and NF- [15] ABDUBAKIEV S, LI H, LU X, et al.N-alkylamides from Piper longum L. and their stimulative effects on the melanin content and tyrosinase activity in B16 melanoma cells[J]. Nat Prod Res, 2020, 34(17): 2510-2513. [16] WANG RM, YANG HX.Research progress of Piper longum and its effective component Piperine[J]. Chinese Pharmaceutical Affairs(中国药事), 2021, 35(3): 350-356. [17] AMEEN F, ALMANSOB A, AL TAMI M, et al.Epigenetic modifiers affect the bioactive compounds secreted by an endophyte of the tropical plant Piper longum[J]. Molecules, 2021, 26(1): 29-44. [18] HUA S, WANG B, CHEN R, et al.Neuroprotective effect of dichloromethane extraction from Piper nigrum L. and Piper longum L. on permanent focal cerebral ischemia injury in rats[J]. J Stroke Cerebrovasc Dis, 2019, 28(3): 751-760. [19] GUO Z, XU J, XIA J, et al.Anti-inflammatory and antitumour activity of various extracts and compounds from the fruits of Piper longum L.[J]. J Pharm Pharmacol, 2019, 71(7): 1162-1171. [20] ZHANG LL, GU J, ZHONG F, et al.Research progress on modern pharmacology of Piper longum[J]. Chinese Journal of Ethnomedicine and Ethnopharma(中国民族民间医药), 2010, 19(11): 35-36. [21] ZHAO XY, QI QG, BAI YF.Observation of protective effect and pathological changes of Piper longum on cold stress-induced gastric mucosal injury in rats[J]. Chinese Herbal Medicine(中国民族医药杂志), 2004(3): 28. [22] RENQING DZ, FENG XM, LAUSANNE DZ, et al.Network pharmacology combined with molecular docking to study the molecular mechanism of tibetan medicine Liuwei Muxiang Pills in the treatment of gastric cancer[J]. Modernization of Traditional Chinese Medicine and Materia Materia-World Science and Technology(世界科学技术-中医药现代化), 2022, 24(1): 309-319. [23] JIANG ZL, ZHU P, REN Y, et al.Study on anti-gastric cancer mechanism and experiment of compound cili mixture based on network pharmacology[J]. ZheJiang Journal of Integrated Traditional Chinese and Western Medicine(浙江中西医结合杂志), 2022, 32(3): 202-206. [24] LI JH, MO Y, XIA L, et al.Mechanism of arnebia root in treatment of cervical cancer based on network pharmacology and molecular docking technology[J]. Journal of Practical Gynecologic Endocrinology(实用妇科内分泌电子杂志), 2021, 8(11): 10-14. [25] ANSARI S, GANTUYA B, TUAN VP, et al.Diffuse gastric cancer: A summary of analogous contributing factors for its molecular pathogenicity[J]. Int J Mol Sci, 2018, 19(8): 2424-2443. [26] SHAN C, ZHANG Y, HAO X, et al.Biogenesis, functions and clinical significance of circRNAs in gastric cancer[J]. Mol Cancer, 2019, 18(1): 136-151. [27] PAN X, TAO H, NIE M, et al.A clinical study of traditional Chinese medicine prolonging the survival of advanced gastric cancer patients by regulating the immunosuppressive cell population: a study protocol for a multicenter, randomized controlled trail[J]. Medicine (Baltimore), 2020, 99(16): 19757-19762. [28] NAKONIECZNA S, GRABARSKA A, KUKULA-KOCH W.The potential anticancer activity of phytoconstituents against gastric cancer-a review on [29] HAQ IU, IMRAN M, NADEEM M, et al.Piperine: a review of its biological effects[J]. Phytother Res, 2021, 35(2): 680-700. [30] MANAYI A, NABAVI SM, SETZER WN, et al.Piperine as a potential anti-cancer agent: a review on preclinical studies[J]. Curr Med Chem, 2018, 25(37): 4918-4928. [31] HSIEH HL, YU MC, CHENG LC, et al.Quercetin exerts anti-inflammatory effects via inhibiting tumor necrosis factor- [32] HUANG YY, BAI L, LEI XP, et al.Tumor necrosis factor receptor superfamily member 4 (TNFRSF4) knockout and establishment of humanized mouse model[J]. Acta Laboratorium Animalis Scientia Sinica(中国实验动物学报), 2021, 29(2): 137-144. [33] CUI X, ZHANG H, CAO A, et al, Cytokine TNF- [34] SILVA FFVE, PADÍN-IRUEGAS ME, CAPONIO VCA, et al. Caspase 3 and cleaved caspase 3 expression in tumorogenesis and its correlations with prognosis in head and neck cancer: a systematic review and Meta-analysis[J]. Int J Mol Sci, 2022, 23(19): 11937-12052. [35] ZHOU M, LIU X, LI Z, et al.Caspase-3 regulates the migration, invasion and metastasis of colon cancer cells[J]. Int J Cancer, 2018, 143(4): 921-930. [36] WAN Q, ZHOU J, WU Y, et al.TNF- [37] GAO SY, LI D.Research progress of tumor necrosis factor and cancer[J]. Chinese Pharmacological Bulletin(中国药理学通报), 2020, 36(9): 1209-1213. [38] WANG Z, LIANG X, XIONG A, et al.Helichrysetin and TNF [39] FANG Y, XIA HM, SUN J, et al.Effects of TNF [40] GONG MJ.Effects of acitretin combined with TNF- [41] MIKAMI K, NAGAYA H, GOTOH A, et al.Naftopidil is useful for the treatment of malignant pleural mesothelioma[J]. Pharmacology, 2014, 94(3-4): 163-169. |
[1] | BU Zixuan, XUE Mengwei, TIAN Jiawei, KE Kaile, WANG Ziying, LI Xiao, LU Tiangong. Interventions of Guizhi Fuling Pills in Properties of Ovarian Cancer Stem Cells [J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 263-270. |
[2] | LIANG Xiaojing, CHEN Xin, NONG Cheng, LI Liang, DING Jian, ZHANG Luyong, JIANG Zhenzhou, WANG Xinzhi. Screening of in vitro Stimulation Methods for iNKT Cells and Conditions for in vitro Activation of iNKT Cells by Triptolide [J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 147-154. |
[3] | GAN Yena, HAN Sheng, YUAN Yi, XUE Lijuan, HUANG Haowen, LI Huanxin, ZHANG Xinci, KUI Siyi, MENG Bofei, LI Qifei, ANARGUL Tudi, LIU Zhifeng, QIN Lingling, LI Duoduo. Possible Molecular Mechanisms of Dachengqi Decoction for Improving Subjective Symptoms of Degenerative Lumbar Spinal Stenosis: a Network Pharmacology Study [J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 162-168. |
[4] | ZHENG Haiyun, ZHANG Wen, WANG Shaonan, ZHAO Haiyu, DU Shouying. Anti-fatigue effects and mechanism of ginseng combined with caffeine in rats [J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 863-870. |
[5] | ZHANG Kaihua, LIU Dingwei, FU Changhai, SUN Xuelin, MIN Xianjun. Effects of rosastatin combined with Danggui Buxue Tang on expressions of AR and NR3C2 [J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 871-877. |
[6] | ZHOU Xiuli, LIU Baosheng, MA Wenming, WANG Qi, WANG Yang, ZHAO Shipeng. Clinical use of cinobufagin preparations in cancer patients [J]. Chinese Journal of Pharmacovigilance, 2024, 21(7): 791-797. |
[7] | AO Ting, WANG Ningning, ZHOU Lei, DENG Huifang, YANG Xingxin, ZHOU Wei, SHEN Pan, GAO Yue. Clinical characterization and mechanism exploration of Fructus Psoraleae-induced hepatotoxicity in zebrafish [J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 611-616. |
[8] | LI Xinlei, GONG Leilei, WANG Xiaoxia, ZHANG Xueyan, ZHAO Han, YAO Weijie, YUAN Sisi, FENG Xin. Molecular mechanism of Yangxue Antai granules for the treatment of recurrent spontaneous abortion based on network pharmacology and molecular docking [J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 366-370. |
[9] | RU Chen, HOU Xiujuan, QIAN Tangliang, DU Mengmeng, LI Yuan, LIU Xiaoping, ZHU Yuelan. Compatibility and mechanism of a Chinese medicine compound in treating Sjogren's syndrome [J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 397-403. |
[10] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
[11] | YIN Xiaoyang, ZHANG Xiaomeng, LIU Zeyu, LIU Yadi, WANG Yu, LIN Zhijian, ZHANG Bing. Cardiotoxicity of Euodia rutaecarpa(Juss.) Benth. Based on Network Pharmacology and Untargeted Metabolomics [J]. Chinese Journal of Pharmacovigilance, 2024, 21(11): 1216-1223. |
[12] | DU Jianmin, ZHANG Chenning, ZHANG Xinghai, ZHANG Wenyu, ZHAO Hengli, WEN Qing. Mechanism of Xinmaitong Tablets against Resistant Hypertension Based on Untargeted Proteomic Analysis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(11): 1270-1275. |
[13] | YANG Zhenzhen, CHANG Cheng, GAO Na, ZHANG Xiaolin, SONG Yinsen, LIU Ying, FAN Tianli. Molecular mechanism of luteolin for inhibiting esophageal squamous cell carcinoma based on network pharmacology and in vitro studies [J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 992-1001. |
[14] | YIN Yuling, HU Chujuan, ZHANG Xiaomeng, WANG Yu, ZHANG Bing, LIN Zhijian. Mining and validation of anti-adriamycin cardiotoxic effect of chicory extract [J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 858-865. |
[15] | MEI Yu, ZHU Yue, ZHANG Huiting, XIAO Chengrong, GAO Yue, MA Zengchun. Protective mechanism of Chinese medicine compound CB001 against low dose radiation based on network pharmacology and experimental verification [J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 872-879. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||